<DOC>
	<DOCNO>NCT00063752</DOCNO>
	<brief_summary>The purpose study determine use PI-0824 patient Pemphigus vulgaris safe .</brief_summary>
	<brief_title>Safety Study PI-0824 Treat Pemphigus Vulgaris</brief_title>
	<detailed_description>Pemphigus vulgaris ( PV ) autoimmune disease affect approximately 40,000 people worldwide . People PV produce antibody attack cell skin , result blister , leave untreated , lead devastate infection discomfort . Currently , doctor treat patient PV prescribe high-dose steroid drug suppress immune system effort decrease production antibody . Unfortunately medication associate serious difficult side effect often result discontinuation use . Peptimmune , Inc. develop new therapy treatment PV , PI-0824 . The goal therapy reduce production antibody cause PV blister act disease cause component immune system . It hop use PI-0824 reduce potentially eliminate need high dose steroid drug suppress immune system .</detailed_description>
	<mesh_term>Pemphigus</mesh_term>
	<criteria>Currently experience stable disease course medication regimen . Currently take daily corticosteroid therapy PV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2005</verification_date>
</DOC>